Pivotal phase III trial of asimadoline in patients with diarrhoea-predominant irritable bowel syndrome.

Trial Profile

Pivotal phase III trial of asimadoline in patients with diarrhoea-predominant irritable bowel syndrome.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2010

At a glance

  • Drugs Asimadoline (Primary)
  • Indications Irritable bowel syndrome
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 05 Apr 2010 Status changed from planning to not yet recruiting, as reported by Tioga Pharmaceuticals.
    • 18 Feb 2010 According to a Tioga Pharmaceuticals media release, this trial along with another trial (see trial profile 700053728) are required US FDA approval.
    • 22 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top